Table 1 Relationship between clinicopathological characteristics and hsa_circ_0005397 expression in patients
From: Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3
Clinicopathological characteristics | Hsa_circ_0005397 expression | P value | |||
|---|---|---|---|---|---|
Low expression | High expression | ||||
Age(years) | Â | 0.881 | |||
> 60 | 12(42.9%) | 13(44.8%) |  | ||
≤ 60 | 16(57.1%) | 16(55.2%) | |||
Gender | Â | 0.612 | |||
Male | 88821(75%) | 20(69.0) | Â | ||
Female | 7(25%) | 9(31%) | |||
Tumor size(cm) | Â | 0.025 | |||
<4.5 | 17(60.7%) | 9(31%) | Â | ||
≥ 4.5 | 11(39.3%) | 20(69%) | 0.190 | ||
Vascular invasion | Â | ||||
Yes | 21(75.0%) | 17(58.6%) | Â | ||
No | 7(25.0%) | 12(41.4%) | Â | ||
Tumor Stage | Â | 0.018 | |||
I-II | 13(46.4%) | 5(17.2%) | Â | ||
III-IV | 15(53.6%) | 24(82.8%) | Â | ||